Abstract Details

Title Effects of Cladribine Tablets in Lymphocyte Subtypes: Insights from the Phase III, 96-Week, Double-Blind CLARITY Study

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 216

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
	No disclosure on file
Isabelle Guilleret, PhD (EMD Serono, Inc.)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Robert Weissert, MD, FAAN (University of Regensburg Medical School)	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��